BPH-715

CAS No. 1059677-23-4

BPH-715( —— )

Catalog No. M26633 CAS No. 1059677-23-4

BPH-715 inhibits the liver-stage growth of P. falciparum with an IC50 of 10 μM for P. falciparum exoerythrocytic forms in HepG2 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 258 In Stock
5MG 235 In Stock
10MG 353 In Stock
25MG 616 In Stock
50MG 907 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BPH-715
  • Note
    Research use only, not for human use.
  • Brief Description
    BPH-715 inhibits the liver-stage growth of P. falciparum with an IC50 of 10 μM for P. falciparum exoerythrocytic forms in HepG2 cells.
  • Description
    BPH-715 inhibits the liver-stage growth of P. falciparum with an IC50 of 10 μM for P. falciparum exoerythrocytic forms in HepG2 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Anti-infection| Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1059677-23-4
  • Formula Weight
    423.383
  • Molecular Formula
    C17H31NO7P2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?0.5 M NaOH : 80 mg/mL (188.96)
  • SMILES
    CCCCCCCCCCOc1ccc[n+](CC(P(O)(O)=O)P(O)([O-])=O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Thorgeirsdóttir TO, et al. Antimicrobial activity of monocaprin: a monoglyceride with potential use as a denture disinfectant. Acta Odontol Scand. 2006 Feb;64(1):21-6.
molnova catalog
related products
  • Xylan

    Xylan represents the main hemicellulose component in the secondary plant cell walls of flowering plants.

  • Lactiflorin

    Lactiflorin is a monoterpene glycoside from paeony root. Lactiflorin possesses nephroprotective effect.

  • Citreorosein

    Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.